Home › Lung Diseases › Maryland
Lung Diseases clinical trials in Maryland
13 studies for Lung Diseases are looking for participants at sites in Maryland.
Cities in Maryland
Study of the Disease Process of Lymphangioleiomyomatosis
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 16 to 100 · All sexes · Updated Oct 2, 2026 · NCT00001465Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Oct 2, 2026 · NCT01730092Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Annapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05624450A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Centennial Medical Group, Columbia
- Jadestone Clinical Research, Silver Spring
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Johns Hopkins Hospital, Baltimore
- Jadestone Clinical Research, Silver Spring
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474American Lung Association (ALA) Lung Health Cohort
- Johns Hopkins University, Baltimore
RecruitingObservational studyHealthy volunteers welcome
Ages 25 to 35 · All sexes · Updated Sep 23, 2026 · NCT04543461Study of Lung Proteins in Patients With Pneumonia
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 3 to 99 · All sexes · Updated Sep 22, 2026 · NCT00077909Role of Genetic Factors in the Development of Lung Disease
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 90 · All sexes · Updated Sep 10, 2026 · NCT00001532A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Johns Hopkins Bayview Medical Center, Baltimore
- USO - Maryland Oncology Hematology, Columbia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Johns Hopkins University, Baltimore
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091Cooperative Assessment of Late Effects for SCD Curative Therapies
- Johns Hopkins Hospital, Baltimore
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 4 to 65 · All sexes · Updated Jul 27, 2026 · NCT05153967Deep Functional Phenotyping of the ALA Lung Health Cohort
- Johns Hopkins University, Baltimore
RecruitingObservational studyHealthy volunteers welcome
Ages 25 to 35 · All sexes · Updated Jul 17, 2026 · NCT06177717Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Recruiting
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT02984761From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.